Our Team
Lucida Medical brings together some of the foremost experts in AI technology and radiology, from leading clinical institutes across Europe.
Our core team is deeply grounded in AI software development and revolutionary applications of medical imaging, both in clinical practice and market development.
Dr Antony Rix
CEO & Co-Founder
PhD Machine learning and AI
Co-founder, Psytechnics (acquired 2011 by Netscout) – patented AI & International standard
Senior Consultant, TTP; CEO & Co-founder, 8power
Expert in software, medical devices & AI development
Professor Evis Sala
Chief Medical Officer & Co-founder
Professor of Oncological Imaging, University of Cambridge & Hon. Consultant Radiologist, Addenbrooke’s Hospital
Former Chief of Body Imaging, Memorial Sloan Kettering Cancer Centre & Professor of Radiology, Weill Cornell Medical College
Board Certified radiologist
Expert in cancer imaging, radiogenomics & AI
Mark Hinton
Chief Technology Officer
Physicist with 30 years of experience in managing complex systems and business processes, including delivery of phase I-III clinical trial programmes for major pharmaceutical companies and innovative biotech and medical device companies.
Former Chief Technology Officer at IAG – Image Analysis Group and Technology Director at Fitch Ratings
Benita Prud’homme
Office and Operations Manager
Benita has worked with 5 technology start-ups in Cambridge, UK, where she joined all of them at early stage and has been pivotal in the scale-up process. Three of these have been spun out from the University of Cambridge.
She has vast experience in administrative services, including PA/EA support and HR.
Alexander Karpul
SENIOR FULL STACK Engineer
Alex has an M.Sc in Computer Science and 10 years of experience in developing software.
Previously, he has built software for Document Automation, UK immigration from SA, and EFT companies.
Dr Numan Celik
SENIOR Machine learning Engineer
Numan has a PhD in Biomedical Engineering with machine learning and AI. By applying machine and deep learning algorithms to several clinical projects, he has worked on analysing the biomarkers of Parkinson’s Disease, cardiovascular disease as well as quantifying the single cell metabolism. Previously, he was post-doctoral researcher at Oxford University and was working on a medical imaging project that was aimed to predict gastrointestinal types of cancers including esophageal, gastric and colon cancers at early stages by adapting AI and computer vision algorithms.
Giovanni Maggi
HEAD OF QUALITY AND REGULATORY
Extensive auditing experience including MDSAP and MDR
Formerly Quality Manager at Vision RT
Steffi le Conte
CLINICAL RESEARCH MANAGER
Steffi brings over 12 years’ experience managing complex clinical trials and research projects, first at Oxford University and then at Ultromics. She led the Ultromics Phase 4 NHSX AI Award where she ensured the rapid deployment of AI in NHS centres. Steffi now leads the Research portfolio at Lucida Medical.
Dr Fabio Geraci
machine Learning engineer
Professional focus includes data analysis and visualisation, machine learning, finite element analysis, and structural analysis.
Previously, a Senior Consultant and FE Specialist for Rolls-Royce UK and a senior FEA Specialist at Red Bull Racing and Red Bull Technology.
Dr Nádia Moreira da Silva
machine Learning engineer
Nadia is a bioengineer with 8 years of experience in medical imaging analysis, with a focus on using machine learning techniques and graph theory to aid in the prognosis of neurological disorders. Previously she worked as a researcher at INESC-Tec developing imaging solutions for clinical partners.
Julian Hains
Head of finance
Very experienced financial and management accountant, who works with investors, businesses, and charities undergoing transformation phases (Start-up, significant growth, or turn around.)
He is also CFO at Smarter Cardiovascular Outcomes by Research and Education Limited.
Previously he was CFO at a company specialising is prostate cancer diagnosis and treatment
StJohn Brown
Commercialisation advisor
Medical Imaging Entrepreneur
Partner, London Uroradiology
Co-founder of multiple medical imaging and biopsy businesses.
Co-founder, Nuada Medical Group, the pioneer of prostate MRI in private practice 2009 – 2015.
Ran Philips Medical Global Service business 1998 – 2001
Marcus Clark
Market & business development Advisor
Co-founder, Prostate Matters
Co-founder, Nuada Medical Group 2009 – 2018
Co-founder, Market Equity Ltd a collaboration with Cranfield School of Management 1994 – 2018
Extensive global go-to-market experience with diagnostic imaging companies
Outstanding network of relationships across the prostate diagnosis and treatment market in the UK and Europe
Louise Mustoe
Social Media & Marketing Consultant
Louise is highly experienced at Social Media strategy and execution as well as events promotion and management.
Further, her work at ICIS means she has developed global relationships with many key players in prostate cancer diagnostics.
She is also Social Media & Campaign Manager at Prostate Matters and Marketing Events Manager at the International Cancer Imaging Society (ICIS)
Previously Training and Conference Manager Bowel Cancer UK
Professor Anwar Padhani
Clinical Advisor
Internationally recognised Oncological MRI radiologist and authority on prostate & whole body imaging
Professor of Cancer Imaging, Institute of Cancer Research
Consultant Radiologist & Head of Imaging Research, Paul Strickland Scanner Centre, Mount Vernon Cancer Centre, London
Co-chair, International PI-RADS (prostate imaging) standards group
Professor Guiseppe Petralia
Clinical Advisor
Director, Precision Imaging & Research Unit, European Oncology Institute (IEO)
Associate Professor, Department of Oncology and Hematology-Oncology, University of Milan
Expert on prostate & whole body MRI for oncology screening, diagnosis, biopsy and treatment management
Our Partners
We collaborate with Cambridge University, we are a partner in the ReIMAGINE prostate imaging trial, are in the process of establishing collaborative partnerships with several UK NHS Trust hospitals to help further develop and validate and test Pi, our AI system for detecting prostate cancer from MRI.
